| Model: | Kalman |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| GTBP | GT Biopharma Inc | Healthcare | Biotechnology | 13 | 7.1 | 56615 | |
| MINT | PIMCO Enhanced Short Maturity Active Exchange-Traded Fund | 0 | 100.65 | 1536093 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| δ: | 0.0001 | Ve: | 0.001 | Neutrality: | dollar |
| Aux StdDev Per: | 0 | Unstable Period: | 20 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2014.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 134863.42 |
| Total net P/L: | 124863.42 | Total ROI: | 1248.63 % |
| CAGR: | 379.23 % | Max. DD: | 66.17 % |
| System Score: | 163.305 | Sharpe Ratio: | 2.231 |
| Start Date: | 2025-01-02 | End Date: | 2026-08-31 |
| Total days: | 606 | ||
| Commissions: | 13217.92 | Comm.% P/L | 9.57 % |
| Total Transactions: | 872 | Log. Linearity: | 75.515 % |
| Total | Long |
Short |
GTBP | MINT | |
|---|---|---|---|---|---|
| Total Profit/Loss | 138081.34 | 28006.50 | 110074.84 | 139649.06 | -1567.72 |
| Total Profit | 468208.96 | 227242.57 | 240966.39 | 469529.30 | 3564.71 |
| Total Loss | 330127.62 | 199236.07 | 130891.55 | 329880.24 | 5132.42 |
| Profit Factor | 1.42 | 1.14 | 1.84 | 1.42 | 0.69 |
| Trades | 218 | 111 | 107 | 218 | 218 |
| Winning Trades | 166 | 79 | 87 | 166 | 88 |
| Losing Trades | 52 | 32 | 20 | 52 | 123 |
| % Profitable | 76.00 | 71.00 | 81.00 | 76.00 | 40.00 |
| Profit/Loss Per Trade % | 1.27 | 0.49 | 2.08 | 1.28 | -0.01 |
| Profit Per Trade % | 4.39 | 4.37 | 4.40 | 4.40 | 0.06 |
| Loss Per Trade % | 7.46 | 7.77 | 6.96 | 7.47 | 0.06 |
| Days In Trade | 550 | 293 | 257 | 550 | 550 |
| Days In Trade (Avg. Per Trade) | 2.52 | 2.64 | 2.40 | 2.52 | 2.52 |
| % Days In Trade | 90.76 | 48.35 | 42.41 | 90.76 | 90.76 |